Atlas Trials

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Clinical trial NCT06773026 · RECRUITING

Trial details

NCT number
NCT06773026
Sponsor
Jerry Vockley, MD, PhD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Start date
2025-06-30
Primary completion
2027-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.